EMULATE

History

Year	Detail
1994	Founded in 1994 by James Yu, the company provides the isolation and purification of Primary Cells and their culture in optimized cell-type-specific media.
2019	Emulate Inc. collaborated with INTENZE on innovative approaches for predicting human response to tattooing, expanding the functionality of Organs-on-Chips technology for chemical risk assessment applications.
2022	Emulate launched a new colon immune cell recruitment application, enabling the most human-relevant preclinical assessment of inflammatory bowel disease (IBD) drug candidates.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.